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Daniel P. Heruth 1, Guanghua Lei3 and Shui Qing Ye1,2

Abstract
Nicotinamide phosphoribosyltransferase (NAMPT) functions in NAD synthesis, apoptosis, and inﬂammation.
Dysregulation of NAMPT has been associated with several inﬂammatory diseases, including rheumatoid arthritis (RA).
The purpose of this study was to investigate NAMPT’s role in arthritis using mouse and cellular models. Collageninduced arthritis (CIA) in DBA/1J Nampt+/− mice was evaluated by ELISA, micro-CT, and RNA-sequencing (RNA-seq). In
vitro Nampt loss-of-function and gain-of-function studies on osteoclastogenesis were examined by TRAP staining,
nascent RNA capture, luciferase reporter assays, and ChIP-PCR. Nampt-deﬁcient mice presented with suppressed
inﬂammatory bone destruction and disease progression in a CIA mouse model. Nampt expression was required for the
epigenetic regulation of the Nfatc1 promoter and osteoclastogenesis. Finally, RNA-seq identiﬁed 690 differentially
expressed genes in whole ankle joints which associated (P < 0.05) with Nampt expression and CIA. Selected target was
validated by RT-PCR or functional characterization. We have provided evidence that NAMPT functions as a genetic risk
factor and a potential therapeutic target to RA.

Introduction
Rheumatoid arthritis (RA) is characterized by synovial
inﬂammation and bone erosion1,2. Unfortunately, current
therapies for arthritis are inadequate and there remains a
need for additional therapeutic targets.
Nicotinamide phosphoribosyltransferase (NAMPT) is
an essential gene3 which functions in NAD synthesis,
apoptosis, and inﬂammation4. NAMPT is expressed in
nearly all organs, tissues, and cells examined4. Because of
its pleiotropic functions, dysregulated NAMPT expression
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has been implicated in the pathogenesis of several diseases, including arthritis, though the role of NAMPT in
these disorders remains to be elucidated4. Using a
collagen-induced arthritis (CIA) mouse model, Busso
et al. demonstrated that FK866, a NAMPT inhibitor,
effectively reduced the severity and progression of
arthritis5. The progression of CIA was also slowed by
selective siRNA knockdown of NAMPT in Ly6Chigh
monocytes6. However, no study has been conducted to
systematically evaluate the molecular mechanisms of
Nampt in arthritis in well-established Nampt knockdown
(Nampt+/−) and Nampt overexpression (NamptOE) mice
to substantiate that Nampt is a genetic risk factor and
potential therapeutic target in RA.
This study investigated the molecular mechanisms of
Nampt in arthritis through integrative approaches of CIA
mouse models, in vitro cellular experimentation, and
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transcriptional proﬁling. We validated Nampt’s involvement in arthritis using a CIA mouse model7,8 in wild-type
and Nampt heterozygous knockdown DBA/1J mice, and
we investigated further the pathways underlying Nampt’s
mechanism in arthritis through loss-of-function and gainof-function studies experiments in mouse bone marrowderived macrophages (BMM) and RNA sequencing
(RNA-seq) of CIA mouse tissue. Selected targets from
RNA-seq discovery were experimentally validated. Our
results support the hypothesis that NAMPT is a genetic
risk factor and a potential therapeutic target in RA.

Results
Decreased inﬂammation and suppressed bone erosion in
collagen-induced arthritis in DBA/1J Nampt+/− mice

To explore the molecular mechanisms of altered Nampt
expression in arthritis, we characterized CIA in Nampt+/−
and Nampt+/+ mice. The progression of observable
inﬂammation was less severe in Nampt+/− mice compared to Nampt+/+ with a signiﬁcant difference in the
median arthritic index from day 28 to 70 postimmunization (Fig. 1a). The incidence of arthritis (index
score > 1) was decreased slightly in Nampt+/− mice (85%,
11/13) compared to Nampt+/+ (100%, 11/11). At day 70
post-immunization, the mice were euthanized for tissue
isolation and sample analysis.
To elucidate potential mechanisms by which the
induction of arthritis is suppressed in Nampt+/− mice, we
measured the serum levels of the arthritogenic anti-mouse
CII auto-antibody, which plays a crucial role in the
initiation of CIA7. The serum levels of the CII antibody
were decreased signiﬁcantly in Nampt+/− mice compared
with Nampt+/+ mice (Fig. 1b). The decreased immune
response corresponded with lower levels of circulating
Nampt in the heterozygous mice compared to wild-type
mice (Fig. 1b).
To evaluate the effect of CIA on focal bone loss, we
analyzed the hind paw and talus by micro-computedtomographic (micro-CT) imaging. Micro-CT revealed
visible differences between the hind paw and talus of
Nampt+/+ and Nampt+/− mice with CIA (Fig. 1c). To
quantify bone loss, we contoured the talus to determine
bone volume (BV). The average total BV of the talus were
signiﬁcantly lower in both CIA Nampt+/+ and Nampt+/−
mice compared with their non-immunized controls
(Fig. 1d). Correction of the BV by the total volume of the
talus (BV/TV) revealed bone loss was signiﬁcantly milder
in CIA Nampt+/− compared with CIA Nampt+/+ mice
(Fig. 1d).
Attenuated osteoclastogenesis in Nampt-deﬁcient primary
BMM and RAW 264.7 cells

Our ﬁnding that Nampt+/− mice were protected against
bone erosion in CIA led us to hypothesize that Nampt
Ofﬁcial journal of the Cell Death Differentiation Association
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plays a critical role in osteoclast differentiation and that
decreased Nampt expression attenuates osteoclast formation. To test this potential mechanism, we examined
Rankl-dependent osteoclast differentiation in BMM isolated from Nampt+/+ and Nampt+/− mice (Fig. 2). TRAP
activity, a histochemical marker of osteoclastogenesis9,
was detected by cell staining (Fig. 2a). M-CSF-dependent
Nampt+/+ BMM were able to produce TRAP+ cells following a 3-day stimulation with M-CSF and Rankl, while
stimulated Nampt+/− BMM produced signiﬁcantly fewer
TRAP+ cells. The relative number of differentiated
osteoclasts from Nampt+/− BMM was signiﬁcantly lower
compared with Nampt+/+ BMM (Fig. 2a). Decreased
differentiation of Nampt-deﬁcient macrophages into
TRAP+ cells correlated with lower expression of Acp5, the
gene encoding TRAP protein. mRNA levels for key
osteoclast markers, including Nfatc1, Dc-stamp, and
Cathepsin K, were also lower in osteoclasts derived from
Nampt+/− BMM compared with Nampt+/+ controls, thus
validating the attenuation of osteoclastogenesis (Fig. 2b).
Western blot analyses veriﬁed that Nampt expression
was decreased in Nampt+/− BMM relative to Nampt+/+
BMM (Fig. 2c).
To investigate the mechanism by which Namptdeﬁciency attenuated macrophage differentiation into
TRAP+ cells, we examined the expression of Nfactc1, an
essential transcriptional regulator of osteoclast differentiation10. Silencing of Nampt expression by siRNA in
RAW 264.7 cells inhibited expression of Nfatc1 protein
and mRNA (Fig. 3a). To determine the regulatory
mechanism of Nfatc1 expression, we tested mRNA stability in response to decreased Nampt levels. Although
there was a decrease in mRNA stability, it was not sufﬁcient to account entirely for the loss in protein levels (data
not shown). Therefore, we investigated Nfatc1 transcription using luciferase reporter and nascent RNA capture
assays. The relative luciferase activity decreased signiﬁcantly in RAW 264.7 cells co-transfected with the
Nfatc1 promoter luciferase reporter and Nampt siRNA
relative to the Nfatc1 promoter luciferase reporter and
scrambled siRNA control cells (Fig. 3b). Nascent RNA
capture in RAW 264.7 cells validated further that synthesis of Nfatc1 mRNA required Nampt expression
(Fig. 3b).
Epigenetic re-modeling of the Nfatc1 promoter plays a
critical role in Nfatc1 expression11. Therefore, we performed ChIP-PCR analyses in Nampt-deﬁcient RAW
264.7 cells to characterize the transcriptional regulation of
the Nfatc1 promoter. The interaction of acetylated histones, which represents open chromatin, with the Nfatc1
P1 promoter decreased following Nampt knockdown
(Fig. 3c). Conversely, the presence of methylated histones,
which represents closed chromatin, increased at the
Nfatc1 P1 and P2 promoter regions following Nampt
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Fig. 1 Decreased NAMPT expression attenuates inﬂammation and bone erosion in collagen-induced arthritis. CIA was induced in 8 weeks
old, male DBA/1J Nampt+/+ and Nampt+/− mice. Observable inﬂammation was observed for 10 weeks. Serum and hind limbs were collected for
ELISA and micro-CT analysis, respectively. a Changes in joint inﬂammation scores in Nampt+/+ (n = 11) and Nampt+/− (n = 13). Arthritic index score
is reported as mean ± median absolute deviation. b Serum concentrations of anti-collagen antibody (scale ×100,000) and NAMPT. The results are
presented as mean ± SD; Nampt+/+ CIA (n = 3), Nampt+/− CIA (n = 5). c Representative micro-CT images of left hind paws and talus bones. Arrow
represents the location of the talus in ankle joint. d Bone volume (BV) and bone volume per total volume (BV/TV) in talus are presented as mean ± SD;
Nampt+/+ (n = 5), Nampt+/− (n = 4), Nampt+/+ CIA (n = 6), 7 Nampt+/− CIA (n = 6). *P < 0.05, **P < 0.005

siRNA knockdown compared with scrambled siRNA
transfected controls (Fig. 3c). These observations corresponded with decreased histone acetyltransferase (HAT)
activity in RAW 264.7 cells subjected to Nampt knockdown (Fig. 3d). The epigenetic remodeling was consistent
with the decreased transcriptional activity observed by
luciferase reporter and nascent RNA capture assays
(Fig. 3b).
To determine if Nampt enzymatic activity was
required for the Nampt–NfatC1–osteoclastogenesis
pathway, we treated RAW 264.7 and Nampt+/+ BMM
with the enzymatic inhibitors, FK86612 and MC413
during Rankl-induced differentiation. Formation of
TRAP+ cells was decreased signiﬁcantly in RAW 264.7
cells treated with FK866 and MC4 relative to the
DMSO-vehicle control cells (Fig. 4a, b). Differentiation
of Nampt+/+ BMM also decreased signiﬁcantly in
response to FK866 and MC4 relative to the control cells
(Fig. 4c, d). In both RAW 264.7 cells and Nampt+/+
BMM, MC4 was as effective as MTX in blocking the
formation of TRAP+ cells. The combination of MC4 and
MTX in RAW 264.7 and Nampt+/+ BMM signiﬁcantly
Ofﬁcial journal of the Cell Death Differentiation Association

blocked osteoclast differentiation compared with MC4
or MTX treatment alone (Fig. 4b, d). These ﬁndings
strongly support the requirement of Nampt enzymatic
activity to promote osteoclastogenesis.
Transcriptomic proﬁling of whole ankle joints in CIA mice
identiﬁes genes and pathways associated with
osteoclastogenesis

To investigate the molecular mechanisms of Nampt in
the pathogenesis of arthritis, we sequenced RNA isolated
from whole ankle joints of Nampt+/+ and Nampt+/− mice
with and without CIA (Fig. 5). We initially determined the
DEG in two comparison groups. There were 1613 DEG in
CIA Nampt+/+ mice compared with non-CIA control
Nampt+/+ mice and 1778 DEG in CIA Nampt+/− mice
compared with CIA Nampt+/+ mice. Comparison of these
two lists identiﬁed 721 genes that were present in both
groups (Fig. 5a), with 690 genes inversely regulated
(Fig. 5b). We hypothesized these 690 genes were associated with Nampt’s role in the pathogenesis of CIA
(Supplemental Table 1). The top ﬁve up-regulated protein-encoding genes in CIA Nampt+/+ ankle were Oscar,
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Fig. 2 Inhibition of Rankl induced osteoclastogenesis in macrophages from Nampt+/− mice. a Bone marrow-derived macrophages from
Nampt+/+ and Nampt+/− mice were treated with M-CSF (20 ng/ml) for 2 days. Non-adherent cells were washed out and cells were further cultured
with M-CSF (20 ng/ml) and Rankl (100 ng/ml) for an additional 3 days. TRAP staining was performed 3 days later and cells having 3 or more nuclei
were counted as osteoclasts. The frequency of osteoclasts is expressed as mean ± SD (N = 5). An average of 7 ﬁelds/well were counted per
experimental sample. b Reduced osteoclast target gene expression in Nampt-deﬁcient macrophages from Nampt+/− mice. Osteoclast target Nfatc1,
Acp5, Dc-stamp, Cathepsin K mRNA expression were measured using semi-quantitative RT-PCR. β-Actin was used as a loading control. c
Representative western blot of Nampt protein in Nampt-deﬁcient macrophages. Quantiﬁcation of Nampt protein expression in Nampt-deﬁcient
macrophages. Representative images from three Nampt+/− mice with Nampt+/+ littermate controls are presented. Quantiﬁcation of semiquantitative RT-PCR of osteoclast target genes expressed as mean ± SD (N = 3). *P < 0.05; **P < 0.005

Cxcl5, Tnn, Fam229a, and Atp6v0d2, while the top ﬁve
down-regulated genes were Lep, Polr3g, Serpina3c,
Pnpla3, and Nnat. Although the majority of the 690 DEG
in the CIA Nampt+/+ ankle were protein-coding genes,
Ofﬁcial journal of the Cell Death Differentiation Association

there were 10 non-coding RNA genes that were differentially expressed (Supplemental Table 1).
The ﬁnding that two osteoclast-speciﬁc genes, Oscar
and Atp6v0d2, were among the top 5 up-regulated genes

Li et al. Cell Death Discovery (2019)5:62

A
SC

KD
100-

Nampt siRNA

Nfatc1

56-

Nampt

37-

Gapdh

Relative quantification
of Nfatc1

Page 5 of 13

1.2
1.0

0.8
0.6

**

0.4
0.2
0.0

Nfatc1 relative
luciferase activity

B

Fold loss of EU labeled
Nfatc1 RNA

SC
1.2

1
0.8
0.6

**

0.4
0.2
0

SC

C

SC

Nampt siRNA

1.2
1
0.8

0.6

**

0.4
0.2
0

SC

SC

Nampt siRNA

Nampt siRNA

Nampt siRNA

Nampt siRNA

Acetyl histone H3L9

H3K4Me3 Nfatc1-P1

H3K27Me3

H3K27Me3 Nfatc1-P1

H3K4Me3 Nfatc1-P2

Input

D

Histone Acetyl Transferase
Activity

Input
1.2
1

*

0.8
0.6

0.4
0.2
0

SC

Nampt siRNA

Fig. 3 Nampt regulates the transcription of Nfatc1 by epigenetic remodeling of the promoter in RAW 264.7 cells. a Nfatc1 expression is
inhibited by the Nampt siRNA treatment. Nfatc1 protein expression in Nampt knocked down RAW 264.7 cells was measured by western blot. Equal
amounts (20 µg) of whole cell lysates were immunoblotted for Nfatc1, Nampt, and Gapdh. Relative quantiﬁcation of Nfatc1 gene expression in
scrambled control and Nampt siRNA transfected RAW 264.7 cells (N = 4). b RAW 264.7 cells were co-nucleofected with scrambled control or Nampt
siRNA and an Nfatc1-Luc reporter construct. Relative Nfatc1 luciferase activities were normalized to non-stimulated scrambled siRNA transfected
control cells. Each determination represents the average of three independent experiments. Relative quantiﬁcation of Nfatc1 mRNA following
nascent RNA capture in RAW 264.7 cells nucleofected with either SC siRNA or Nampt siRNA. Transcriptional rates presented as fold loss of EU labeled
control RNA. c ChIP-PCR analysis of RAW 264.7 cells nucleofected with either scrambled siRNA or Nampt siRNA. The P1 region of the Nfatc1 promoter
was ampliﬁed following immunoprecipitation with the acetyl histone lysine 9 antibody and P1 and P2 promoter regions were ampliﬁed following
immunoprecipitation with H3K4Me3 and H3K27Me3 antibodies. d Histone acetyltransferase activity (HAT) in scrambled control and Nampt siRNA
transfected RAW 264.7 cells. *P < 0.05; **P < 0.005

supported our observation that decreased Nampt
expression limited osteoclastogenesis in both RAW 264.7
and BMM. Additionally, the osteoclast-speciﬁc genes
Mmp9, Acp5, Ctsk, and Dcstamp were differentially
Ofﬁcial journal of the Cell Death Differentiation Association

expressed with increased expression in CIA Nampt+/+
mice (Supplemental Table 2). Calcium inﬂux plays a critical role in the activation of Nfatc114. We identiﬁed
19 signiﬁcantly upregulated calcium metabolism genes
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Fig. 4 Inhibition of Rankl induced osteoclasts differentiation by Nampt enzyme inhibitors MC4, FK866 with or without MTX in RAW 264.7
and BMM. a RAW cells were pretreated with 2 nM MC4 or FK866 or 50 nM MTX for 3 h and then stimulated with Rankl (100 ng/ml) for 5 days. TRAP
staining was performed using a TRACP and ALP double staining kit. b The frequency of TRAP-positive cells expressed as mean of triplicate
determinations ± SD. c BMM were isolated from wild-type mice pretreated with 2 nM MC4 or FK866 or 50 nM MTX for 3 h and then stimulated with
Rankl (100 ng/ml) for 5 days. TRAP staining was performed using a TRACP and ALP double staining kit. d The frequency of TRAP-positive cells
expressed as mean of triplicate determinations ± SD. *P < 0.05; **P < 0.005; ***P < 0.001

within the 690 DEG (Supplemental Table 3). Our previous ﬁnding that knockdown of NAMPT expression
signiﬁcantly attenuated calcium inﬂux into human pulmonary artery endothelial cells15, supports our hypothesis
that decreased Nampt expression may inhibit osteoclast
differentiation by inhibiting calcium inﬂux via mediating
expression of calcium metabolism genes.
To gain further insight into the biological functions
associated with Nampt mediated pathogenesis of CIA, we
submitted the 690 DEG for pathway analysis. These
include several pathways associated with osteoclastogenesis, including the Inhibition of Matrix Metalloproteases
and the Role of Osteoblasts, Osteoclasts and Chondrocytes
in Rheumatoid Arthritis (Fig. 5c, Supplemental Table 4).
IPA analysis predicted target molecules in the dataset of
690 DEG that are either activated or inhibited by wellcharacterized upstream regulators. TNFα (5.575 activation z-score; 7.73E−46 P-value of overlap), TGFB1 (5.436;
Ofﬁcial journal of the Cell Death Differentiation Association

9.4E−36), and LPS (5.985; 4.87E−32) are the top 3 activators, while the top 3 inhibitory regulators are the drugs
dexamethasone (−3.074; 2.12E−34) and rosiglitazone
(−4.791; 7.56E−24), and the kinase inhibitor PD98059
(−3.847; 1.33E−23) (Supplemental Table 5). Upstream
regulator analysis also identiﬁed factors, such as cytokines
(Tnfsf11, CSF1), transcriptional regulators (Fos, Nfatc1),
and signaling proteins (Nfκb, Erk1/2, P38 Mapk, Src,
P13k, Akt) that are known to promote osteoclast differentiation and bone resorption (Supplemental Table 6).
We next performed functional enrichment analyses for
GO terms and KEGG to predict potential biological
processes and pathways involved in the Nampt associated
pathogenesis of CIA. The top biological processes linked
with the 690 DEG include GO:0007155—cell adhesion,
GO:0022610—biological adhesion, GO:0001501—skeletal
system development, GO:0001503—ossiﬁcation and
GO:0060348—bone development (Fig. 5d, Supplemental
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Fig. 5 Transcriptional proﬁles of whole ankle joints of CIA in DBA/1J Nampt+/+ and Nampt+/− mice. a Venn diagram representation of the 721
genes common to the 2 comparison groups. 690 genes were inversely regulated in CIA Nampt+/+/Nampt+/+ and CIA Nampt+/−/CIA Nampt+/+
mice (P < 0.05). b Heat map analysis of 690 signiﬁcantly differentially expressed genes. Individual mouse samples are shown in columns and
differentially expressed genes in rows. Red indicates an increased expression. Blue indicates a decreased expression. N = 2 for each group. c Top 10
canonical pathways as predicted by IPA for the 690 genes as described in Materials and methods. d The top 10 biological processes identiﬁed by the
software program DAVID

Table 7). The top pathways identiﬁed by KEGG analysis
include mmu04512:ECM—receptor interaction and
mmu04142:Lysosome (Supplemental Table 8).
Validation of RNA-seq result by RT-PCR assay of the
selected targets as well as functional validation of
GM26870, a long non-coding RNA

To validate RNA-seq results, we performed RT-PCR
assay of 3 selected targets: Nampt, Chemokine (C–C
motif) ligand 12 (Ccl12), and Vascular cell adhesion
protein 1 (Vcam1). In the control group, Nampt expression levels in Nampt+/− mice were 40% of Nampt+/+
mice, while in the CIA group, Nampt expression levels
were lower than those in the control group. The trend was
similar to the RNA-seq result (Fig. 6a). Ccl2 expression in
Nampt+/− mice was 40% of Nampt+/+ mice in the control
Ofﬁcial journal of the Cell Death Differentiation Association

group, while in the CIA group, Ccl2 expression levels
were lower than the control group with Ccl2 expression in
Nampt+/− mice approximately 50% of Nampt+/+ mice.
The trend was also similar to the RNA-seq result (Fig. 6b).
Vcam1 expression in Nampt+/− mice was about 20%
higher than Nampt+/+ mice in the control group while in
the CIA group, Vcam1 expression levels were all higher
than in those in the control group. The trend was also
similar to the RNA-seq result (Fig. 6c). Although we only
assayed a limited number of targets, the RT-PCR analyses
conﬁrmed the RNA-seq results.
To validate the RNA-seq results functionally and to
initiate signal transduction analyses of Nampt mediated
pathways in CIA Nampt+/− mice, we focused on GM26870,
a differentially expressed long non-coding RNA (lncRNA),
to examine whether it may be a component underlying the

Li et al. Cell Death Discovery (2019)5:62
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Fig. 6 Validation of differential gene expression proﬁles determined by RNA seq via TaqMan™ qPCR analyses of selected targets. RNA
isolation, RNA-seq, and RT-PCR were carried out as described in Materials and methods. All results of gene expression levels are expressed as relative
fold changes. The relative fold changes represent mean values of technical replicates of N = 6 and biological replicates of N = 2. a Comparison of
relative changes in Nampt expression levels for RNA-seq and qPCR. b Relative fold changes for Ccl2. c Relative fold changes Vcam1. All fold changes
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each experimental sample. Gapdh served as the endogenous control. Cont-R control RNA seq, CIA-R CIA RNA seq, Cont-V control TaqMan™
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protective role of Nampt knockdown in arthritis. GM26870
(ENSMUSG00000097312), located on the reverse strand of
Chromosome 9: 3,000,282–3,038,313, encodes 3 transcripts
(splice variants) (Fig. 7a), which all have a length around
1100 bp. Among them, GM26879-201 is 1170 bp. We
employed GM26870-201 dsiRNA synthesized by IDT
(Fig. 7b) to knockdown GM26870-201 in mouse primary
BMM to examine its effect on osteoclast formation. The
knockdown of GM26870-201, successfully measured by
RT-PCR (data not shown), blocked osteoclast formation
(Fig. 7c) in mouse primary BMM.
Overexpression of Nampt promotes osteoclast formation

Since knockdown of Nampt expression inhibits osteoclast formation, we hypothesized that overexpression of
Nampt would promote osteoclast formation. To test this
hypothesis, we isolated BMM from Nampt+/+ and
NamptOE DBA/1J male mice and initiated cell differentiation into TRAP+ osteoclasts (Fig. 8a). As presented
in Fig. 8b, the number of osteoclasts is as high as 450/well
from NamptOE mice cells while only about 200/well in
Nampt+/+ mice cells. Osteoclast density is above 0.25 in
NamptOE mice cells vs. 0.1 in Nampt+/+ mice cells.
Overexpression of Nampt in NamptOE mice cells was
conﬁrmed by western blotting (Fig. 8c). Nfatc1 was also
upregulated in NamptOE mouse cells. Semi-quantitatively,
Nampt and Nfatc1 expressions were 150% and 130%
higher in NamptOE cells than those in Nampt+/+ cells,
respectively. These results indicate that the overexpression of Nampt promotes osteoclast formation via
upregulating Nfatc1.

Discussion
In this study, we discovered that heterozygous knockdown of Nampt suppressed inﬂammatory bone destruction and disease progression in a CIA mouse model. We
characterized one potential mechanism by which Nampt
Ofﬁcial journal of the Cell Death Differentiation Association

affects arthritis through its transcriptional regulation of
the osteoclastogenesis essential transcription factor
Nfatc1. Nampt expression was required for the epigenetic
regulation of the Nfatc1 promoter and osteoclastogenesis.
Finally, we performed transcriptome analysis of whole
ankle joints isolated from Nampt+/+ and Nampt+/− mice
which demonstrated the enrichment of osteoclastogenesis
genes and pathways and provided insight into the roles of
Nampt in the pathogenesis of CIA. Selected targets were
validated by RT-PCR for functional characterization. Our
ﬁndings support our hypothesis that NAMPT is a genetic
risk factor and potential therapeutic target for RA.
The role of Nfatc1 in osteoclastogenesis has been
well characterized. However, the epigenetic regulation of
Nfatc1 transcription by Nampt is a novel ﬁnding.
Knockdown of Nampt expression inhibits Rankl expression (Fig. 2) while overexpression of Nampt upregulates
Rankl expression (Fig. 7). Rankl is an upstream regulator
of Nfatc1. RANKL belongs to the tumor necrosis factor
superfamily and plays a critical role in osteoclast differentiation and bone destruction in RA16. Knockdown of
Nampt expression inhibits Nfatc1 expression as well as
Acp5, Dc-stamp, Cathepsin K mRNA expression which
are known to be involved in osteoclastogenesis (Fig. 2).
NFATc1 is required for sufﬁcient osteoclast differentiation. It plays the role of a master transcription regulator of
osteoclast differentiation17. The dysregulation of the
NAMPT–RANKL–NFATC1–osteoclastogenesis axis may
play a major role in bone erosion associated with chronic
arthritis, which is underlying the role of NAMPT in the
pathogenesis of RA. Two lines of evidence, luciferase
reporter assays and RNA capture experiments, support
that Nampt regulates the transcription of Nfatc1 (Fig. 3).
Our ChIP-PCR analyses in Nampt-deﬁcient RAW 264.7
cells found that the interaction of acetylated histones with
the Nfatc1 P1 promoter was decreased (Fig. 3c) while that
of methylated histones was increased at the Nfatc1 P1 and
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Fig. 7 Knockdown of GM26870-201 expression blocks osteoblast formation from mouse bone marrow-derived macrophages. a Chromosome
location of GM26870 and its encoding of three transcripts (splicing variants). GM26870 is located at Chromosome 9: 3,000,282–3,038,313 reverse strand.
Shown in the left is the transcript GM26870-201 (1170 bp), shown in the middle is GM26870-202 (1170 bp), and shown in the right is GM26870-203
(1143 bp). Image is copied from the Ensembl website (http://useast.ensembl.org/Mus_musculus/Gene/Splice?db=core;g=ENSMUSG00000097312;
r=9:3000282-3038313). b GM26870-201 dsiRNA sequence. The duplex dsiRNA consists of 25 bp in the forward strand and 27 bp in the reverse strand.
c Effect of GM26870-201 knockdown on osteoclast formation in mouse BMM. Cell isolation and culture as well as Trap staining were carried out as
described in Materials and methods. Shown clearly is that knockdown of GM26870-201 expression blocks osteoclast formation from mouse BMM

P2 promoter regions. These observations corresponded
with decreased HAT activity in RAW 264.7 cells subjected
to Nampt knockdown (Fig. 3d). Histone acetylation is
correlated with gene expression activation18. The presence of methyl moieties inhibits gene expression19.
Knockdown of Nampt expression inhibits histone acetylation while enhancing histone methylation of the Nfatc1
gene promoter and hence its expression. Our study provides the ﬁrst evidence that Nampt knockdown inhibits
osteoclast formation via epigenetic inhibition of Nfatc1
gene expression. The epigenetic remodeling was consistent with the decreased transcriptional activity
observed by luciferase reporter and nascent RNA capture
assays (Fig. 3b). Our ﬁnding that the formation of Ranklstimulated TRAP+ cells was blocked by treatment with
Ofﬁcial journal of the Cell Death Differentiation Association

the small molecule Nampt inhibitors, FK86612 or
MC413,20, provides evidence for the requirement of NAD+
in osteoclastogenesis. In addition, the increased inhibitory
effect of an MC4 + MTX combination relative to individual treatments of each drug, support our earlier work
which demonstrated that the inhibition of NAMPT
potentiated the effectiveness MTX21.
A few RNA-seq studies have been applied to rheumatic
diseases22–27. In the present study, RNA-seq analysis of
mouse whole ankle joints identiﬁed 690 genes that are
associated with Nampt’s role in CIA pathogenesis. They
revealed not only “usual suspects” in the pathogenesis such
as upregulation of inﬂammatory activator (TNFα, TGFB1,
and LPS), transcriptional regulators (Fos, Nfatc1), and signaling proteins (Nfκb, Erk1/2, P38 Mapk, Src, P13k, Akt)
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Fig. 8 Overexpression of Nampt promotes osteoclast formation. Bone marrow cells were isolated from male DBA/1J Nampt+/+ and NamptOE
mice and differentiated into osteoclasts. TRAP+ cells with >3 nuclei were counted as osteoclasts as described in Materials and methods. a Images of
TRAP+ cells were captured under a light microscope (magniﬁcation, 10×). b Quantiﬁcation of osteoclasts. c A representative image of western blot
analysis of Nampt, Nfatc1, and β-Actin protein levels in NamptOE BMM. β-Actin was included as a loading control. d Quantiﬁcation of Nampt and
Nfatc1 protein levels. Data were presented as relative expression levels based on the value of Nampt+/+ wild type (WT) mice as 1. *P < 0.05 vs.
Nampt+/+ mice and ***P < 0.001 vs. Nampt+/+ WT mice

that are known to promote osteoclast differentiation and
bone resorption but also provided a number of new targets
and novel insight into the role of Nampt in the pathogenesis
of arthritis. First, we found that two osteoclast-speciﬁc
genes, Oscar and Atp6v0d2, were among the top 5 upregulated genes in CIA Nampt+/+ mice vs. CIA Nampt+/−
mice. OSCAR–collagen interaction stimulates RANKdependent osteoclastogenesis28. OSCAR can play a proinﬂammatory role in monocyte-derived cells and contribute
crucially on multiple levels to RA pathogenesis. The RANK/
c‑Fos/ATP6V0D2 signaling pathway is an important pathway in the osteoclastogenesis29. Second, functional enrichment analyses for GO terms and KEGG to predict potential
biological processes and pathways involved in the Nampt
associated pathogenesis of CIA has identiﬁed many
new targets in biological processes: GO:0001501—skeletal
system development, GO:0001503—ossiﬁcation, and
GO:0060348—bone development (Fig. 5d, Supplemental
Table 7). Third, a number of non-coding RNAs was differentially expressed (Supplemental Table 7) and they are
novel targets which may underlie Nampt’s role in the
pathogenesis of RA. This short discussion just scratches the
surface of our RNA-seq data. It should be mentioned that
we validated RNA results by RT-PCR of selected targets:
Nampt, Ccl2, and Vcam1 (Fig. 6), support the validity of our
RNA-seq results. Thus our RNA-seq data provide a rich
resource for us and others to further experimentation to
Ofﬁcial journal of the Cell Death Differentiation Association

characterize new targets in the pathogenesis of RA in the
future. We also functionally validated one of the differentially expressed lncRNA, GM26870, and found that
knockdown of GM26870 inhibited osteoclast formation
(Fig. 8). It may in part be among the Nampt mediated
pathways. lncRNAs can function as modular scaffolds to
specify higher-order organization in RNP complexes and in
chromatin states30. It forms extensive networks of ribonucleoprotein (RNP) complexes with numerous chromatin
regulators. It is increasingly recognized that lncRNAs play
critical roles in multiple biological processes across all
kingdoms of life30. GM26870’s biological role is thus far
unknown. Our study here provides the ﬁrst gleam into
GM26870’s function or pathological role.
In conclusion, we demonstrated that decreased
Nampt expression attenuates inﬂammatory bone loss
in a Nampt+/− CIA mouse model. In vitro assays
revealed impaired osteoclastogenesis in Nampt-deﬁcient
RAW 264.7 and BMM which corresponded with
epigenetic suppression of Nfatc1 transcription and
may provide a potential mechanism by which the
Nampt–NfatC1–osteoclastogenesis pathway promotes
arthritis. RNA-seq analysis further supported these
observations and uncovered new insights into the
pathways associated with arthritis. In total, our ﬁndings
suggest that NAMPT is a genetic risk factor and
potential therapeutic target for RA.
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Materials and methods
Antibodies and chemicals

RPMI 1640 and DMEM were purchased from Life
Technologies. Lipopolysaccharide-Escherichia coli 055:
B5 was obtained from Sigma Aldrich (#L6529; St. Louis,
MO). TRACP and ALP double staining kit (#MK300) was
purchased from Clontech (Mountain View, CA). AntiTRAP1 antibody (#ab151239) was from Abcam (Cambridge, MA). Phospho-MAPK family antibody sampler
kit (#9910), pNF-κB p105 (#4806), pNF-κBp65 (#3033),
Acetyl-Histone H3 (Lys9) (#9649), Tri-Methyl-Histone
H3 (Lys27) (#9733) antibodies, Simple ChIP Enzymatic
Chromatin IP kit (#9003), and cell lysis buffer (#9803)
were purchased from Cell Signaling Technology (Beverly,
MA). Recombinant Mouse M-CSF (#576406) and puriﬁed anti-NFATc1 antibody (#649601) were purchased
from Biolegend (San Diego, CA). GAPDH (#sc25778),
anti-Mouse and anti-Rabbit secondary antibodies were
from Santa Cruz Biotechnology (Santa Cruz, CA).
Nampt siRNA (Stealth_116; 5′-CCACCCAACACAAGC
AAAGUUUAUU-3′) and Scrambled control siRNA
(stealth_con 116, 5′-CCACAACAACAAACGUUGAU
CCAUU-3′), Click-iT Nascent RNA capture kit
(#C10365), Superscript III ﬁrst strand synthesis supermix
for qRT-PCR (#11752-050), Superscript VILO cDNA
synthesis Supermix (#11754–050), and mouse Rankl
recombinant protein (#RP-8601) were from (ThermoFisher Scientiﬁc, Waltham, MA). TaqMan® gene
expression assays for Nfatc1 (Mm00479445_m1), Acp5
(mCG22832), and TaqMan® gene expression master mix
(#4369016) were purchased from Applied Biosystems
(Foster City, CA). SF cell line 4D Nucleofector X kit was
from Lonza (Alpharetta, GA). Anti-Nampt antibody
(#A300–372A) was purchased from Bethyl Laboratories
(Montgomery, TX).
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(CII, 100 µg, Chondrex) in Complete Freund’s Adjuvant
(CFA, 100 µg Mycobacterium tuberculosis, Chondrex) by
intradermal injection at the base of the tail. A collagen
booster (100 µg) in Incomplete Freund’s Adjuvant (IFA,
Chondrex) was administered at day 218. Mice were evaluated for the onset of inﬂammation and scored (scale 0–4
per paw) as described by Brand et al.8. Mice were scored
twice per week for 10 weeks. At the end of the 10-week
period, the animals were euthanized and tissue was isolated for analysis. Circulating serum levels of anti-mouse
CII antibody (Chondrex) and Nampt (AdipoGen®) were
determined by ELISA. The left hind limb was scanned
with a vivaCT40 (Scanco) in the Skeletal Imaging and In
vitro-In vivo Mechanical Core in the University of Missouri Kansas City, School of Dentistry, as described previously32. The right hind limb was collected for RNA
isolation and gene expression analyses.
Overexpression (NamptOE) mice were generated in our
lab as described previously33.
Isolation of bone marrow-derived macrophage

Isolation of BMM was performed as previously
described34.
In vitro osteoclastogenesis

Osteoclasts were generated from bone marrow as
described previously35.
siRNA mediated Nampt knockdown

RAW 264.7 cells were 4D-nucleofected with Nampt and
scrambled siRNA (50 nM/2 × 106 cells) in SF solution
(Amaxa). Cells were seeded at 5 × 104 nucleofected cells/
well/24-well plate for TRAP staining and 1 × 105 cells/
well/6-well plate for protein isolation.
Protein extraction and western blot analysis

Cell culture

The murine macrophage cell line RAW 264.7 (TIB- 71,
ATCC®) was maintained in RPMI 1640 media containing
10% FBS and antibiotics. All cells were grown at 37 °C, 5%
CO2.
Animal studies

Mice were maintained in an Association for Assessment
and Accreditation of Laboratory Animal Care accredited
institution in a temperature-controlled, pathogen-free
facility with a 12 h light/dark cycle. The mice were gang
housed with free access to food (Irradiated Teklad Global
18% Rodent Diet, Envigo, cat# 2918.15) and water.
DBA/1J mice (The Jackson Laboratory) were crossed with
C57BL/6J Nampt+/− mice31. Offspring were backcrossed
to DBA/1J for >10 generations to develop congenic
DBA/1J Nampt+/−. To induce arthritis, 10-week-old,
male mice were immunized with bovine collagen type II
Ofﬁcial journal of the Cell Death Differentiation Association

Protein extraction and western blot analysis were carried according to our previous procedure33.
ChIP assay

SimpleChIP® Enzymatic Chromatin IP assays (Cell
Signaling Technology) with Acetyl-Histone H3 (Lys9)
and Tri-Methyl-Histone H3 (Lys27) antibodies were
utilized according to the manufacturer’s instruction.
Immunoprecipitated DNA was reverse cross-linked,
puriﬁed and analyzed by PCR (primers: NFATc1-617-F
5′-GGAAGCCTGCGATTTTACAT-3′, NFATc1-426-R
5′-ACGAAACGGGAAGGAAAG-3′).
Histone acetyltransferase (HAT) assay

HAT enzyme activity was quantiﬁed in Namptdeﬁcient and scrambled control cells using an EpiQuik
HAT assay (EpiGentek) according to the manufacturer’s
instruction.
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Luciferase reporter assays

Luciferase reporter assays were performed as described
previously34.
RNA isolation, quantitative RT-PCR, and nascent RNA
capture

RNA isolation, quantitative RT-PCR, and nascent RNA
capture were performed as we previously described36.
RNA-seq

RNA was isolated from ﬂash frozen whole ankle joints
collected after the 10-week CIA observation period.
cDNA sequencing libraries were prepared with an Illumina TruSeq Stranded Total RNA Sample Prep Kit and
subjected to 2 × 101 paired-end sequencing as described
previously3. Mapping of RNA-seq reads and transcript
assembly and abundance estimation were conducted
using Tuxedo Suite pipeline (TopHat v1.3.0/Bowtie
v0.12.7/Cufﬂinks v1.0.3) and reported in Fragments Per
Kilobase of exon per Million fragments mapped (FPKM).
To identify genes which were differentially expressed, fold
changes for each gene were calculated by dividing the
average FPKM for the case by the average FPKM for the
control. We determined fold changes for two comparison
groups: (1) CIA Nampt+/+ mice compared with non-CIA
control Nampt+/+ mice, and (2) CIA Nampt+/− mice
compared with CIA Nampt+/+ mice.
Functional pathway analysis

Kyoto Encyclopedia of Genes and Genomes (KEGG)
analyses to identify cellular pathways and biological processes associated with differentially expressed genes
(DEG) were performed with DAVID37. Ingenuity Pathway
Analysis (IPA) (Ingenuity Systems) predicted functional
and canonical pathways.
Statistics

Statistical analyses were performed with Sigma Stat (v4.0,
Systat Software, Inc.). Results were expressed as mean ± SD.
P < 0.05 was considered statistically signiﬁcant.
Data availability
The RNA-seq data have been deposited to Gene Expression Omnibus (http://
www.ncbi.nlm.nih.gov/geo; accession number GSE121793).
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